Meta-Analysis
Copyright ©The Author(s) 2018.
World J Cardiol. Nov 26, 2018; 10(11): 242-249
Published online Nov 26, 2018. doi: 10.4330/wjc.v10.i11.242
Table 1 Characteristics of the included studies
Study, yrCountryStudy periodStudy designSample size
Cardiac surgery typeFollow up period (mo)
s-LAAONo occlusion
García-Fernández et al, 2003[3]Spain2003retrospective58147MVS69.4 ± 67
Healey et al, 2005[7]Germany2001-2002RCT5225CABG13 ± 7
Nagpal et al, 2009[8]Canada2007-2007RCT2221MVS<1
Whitlock et al, 2013[9]Canada2009-2010RCT2625CABG and VS1
Zapolanski et al, 2013[4]United States2005-2012retrospective808969CABG and VSNR
Kim et al, 2013[6]United States2001-2010retrospective631631CABG and MVS1
Lee et al, 20141[5]Korea1999-2011retrospective119119MVS with AF ablation63 ± 44
Melduni et al, 20171[10]United States2000-2005prospective461461CABG and VS109.2
Elbadawi et al, 20172[11]United States1998-2013retrospective652652VSIn-hospital
Elbadawi et al, 2017[12]United States2004-2013retrospective251912595CABGIn-hospital
Friedman et al, 2018[14]United States2011-2012retrospective38926632CABG, MVS, AVS31.2
Yao et al, 20181[13]United States2009-2017retrospective42954295CABG, VS25.2 ± 22.8
Table 2 Baseline and procedural characteristics of included studies
StudyAge (mean ± SD)
Hypertension
AF (%)
Technique of s-LAAO
s-LAAONo occlusions-LAAONo occlusions-LAAONo occlusion
García-Fernández et al, 2003[3]63 ± 1262 ± 10NRNRNRDouble suturing
Healey et al, 2005[7]72 ± 671 ± 57592178Suture or stapler
Nagpal et al, 2009[8]57.8 ± 13.359.2 ± 11.9NRNR1829Resection
Whitlock et al, 2013[9]77.4 ± 6.874.6 ± 7.692.392100100Amputation and closure or stapler
Zapolanski et al, 2013[4]70.52 ± 11.8383.980.619.910.7Double ligation
Kim et al, 2013[6]66.6 ± 11.465.8 ± 11.680.973.1NRNRLigation and excision
Lee et al, 2014[5]55.9 ± 12.250.7 ± 12.419.814.5100100Amputation
Melduni et al, 2017[10]67.4 ± 12.767.6 ± 13.559614745Amputation, suturing or stapler
Elbadawi et al, 2017[11]70.8 ± 10.271.2 ± 11.170.652.8100100NR
Elbadawi et al, 2017[12]71.3 ± 970.6 ± 8.778.576.1100100NR
Friedman et al, 2018[14]75 ± 5.976.4 ± 6.414.512.750.543.4Any technique
Yao et al, 2018[13]68.2 ± 10.665.8 ± 11.388.690.475.431.4
Table 3 Complications reported in the individual studies
StudyTotal complications
Type of complications
s-LAAO (%) vs No occlusion (%)s-LAAONo occlusion
Healey et al, 2005[7]8 (52) vs 1 (4)8- intraoperative LAA tears1- LAA tear
Nagpal et al, 2009[8]14 (63.6) vs 11 (52.3)1- septicemia 1- myocardial infarction 2- RBC transfusion 8- temporary pacemaker 2- permanent pacemaker1- RBC transfusion 7- temporary pacemaker 3- permanent pacemaker
Whitlock et al, 2013[9]1 (3.8) vs 2 (25)1- major bleeding2- major bleeding
Zapolonski et al, 2013[4]3 (0.3) vs 5 (0.6)3- myocardial infarction5- myocardial infarction
Lee et al, 2014[5]22 (18.4) vs 22 (18.4)9- requirement of dialysis 4- permanent pacemaker insertion 1- wound revision 8- pericardial effusion1- low cardiac output syndrome 10- dialysis 2- permanent pacemaker insertion 1- mediastinitis 2- wound revision 6- pericardial effusion
Melduni et al, 2017[10]32 (6.9) vs 32 (6.9)14- pneumonia 18- acute renal failure14- pneumonia 18- acute renal failure
Elbadawi et al, 2017[11]17 (3.1) vs 9 (1.6)17- pericardial effusion7- pericardial effusion 2- hemorrhage
Elbadawi et al, 2017[12]1030 (40.8) vs 2903 (23)16- cardiac tamponade 68- pericardial effusion 917- hemorrhage 29- postoperative shock19- cardiac tamponade 151- pericardial effusion 2687- hemorrhage 46- postoperative shock